- Home
- Reports
- Pharmaceutical
- Impingement Syndrome Market
Impingement Syndrome Market Information: By Types (Structural Impingement, Functional Impingement), By Diagnosis (Physical Examination, Imaging), By Treatment (Drug Treatment, Non-Pharmacological Treatment, Surgery), By End Users (Hospitals, Physical Therapists) - Global Forecast Till 2023
ID: MRFR/Pharma/2968-HCR | February 2021 | Region: Global | 110 pages
Market Scenario
Impingement syndrome or subacromial impingement occurs when the tendons of the rotator cuff muscles become impinged and inflamed as they pass through the subacromial space. There are two major types of this disease, structural impingement and functional impingement. Different types of diagnosis methods like bone spurs, rotator cuff injury, labral injury, shoulder instability, biceps tendinopathy and scapula dysfunction can be used to diagnose this disorder. Increasing prevalence of orthopedic diseases, rising geriatric population and changing lifestyle have boosted the growth of the market. According to International Osteoporosis Foundation, worldwide osteoporosis causes more than 8.9 million fractures annually. Moreover, increasing healthcare expenditure and government initiatives for research and development have fuelled the market growth. However, high cost surgeries, and lack of awareness about this disorder may slow the growth of the market.
The global impingement syndrome market is expected to grow at a CAGR of ~6.8% during the forecast period 2017-2023.
Research Methodology
Source: World Health Organization, Centers for Disease Control and Prevention, expert interview market research future analysis, annual report, white paper, company presentation
Segmentation
The global impingement syndrome market is segmented on the basis of types, diagnosis, treatment, and end users. On the basis of types, the market is segmented into structural impingement, and functional impingement.
On the basis of diagnosis, the market is segmented into physical examination, imaging, and other. Imaging is further segmented into ultrasonography, arthrography and MRI.
On the basis of treatment, the market is categorized into drug treatment, non-pharmacological treatment, and surgery. Drug treatment is further segmented into corticosteroid, local anesthetic, NSAIDs, and other. Non-pharmacological treatment is further segmented into joint mobilization, interferential therapy, acupuncture, soft tissue therapy, therapeutic taping, rotator cuff strengthening, and other. Surgery segment is subsegmented into arthroscopic surgery, open surgery and others.
On the basis of end user, the market is segmented into hospitals, physical therapists, and others.
Key Players
Some of the key players in this market are ATOS Klinik Heidelberg GmbH & Co. KG (Germany), DePuy Synthes (US), Johnson & Johnson Services, Inc. (US), Stryker Corporation (US), Medtronic (Ireland), Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Abbott (US), Immediate Media Company Ltd. (US)
Figure: Global Impingement Syndrome Market, by Treatment, 2016 (%)
Source: World Health Organization, Centers for Disease Control and Prevention, expert interview market research future analysis, annual report, white paper, company presentation
Regional Analysis
The America dominates the global impingement syndrome market owing to the presence of huge geriatric population, increasing number of patient suffering from orthopedic diseases and increasing healthcare expenditure. Moreover, high healthcare speeding is another major factor contributing to the market growth.
Europe accounts for the second largest impingement syndrome market across the globe owing to increasing government support for research & development, increasing investment in healthcare, and well developed healthcare sector.
Asia Pacific has the fastest growing market, increasing government support for research & development, increasing prevalence of chronic diseases, huge population base and rapidly developing economy drives the growth of the market in this region.
The Middle East & Africa is expected to show a least market share due to less availability of medical facilities, and less development in healthcare domain.
Intended Audience
Pharmaceutical Companies
Medical Devices Manufacturer
Research and Development (R&D) Companies
Market Research and Consulting Service Providers
Potential Investors
Frequently Asked Questions (FAQ) :
Global impingement syndrome market is projected to grow at approximately 5.3% CAGR during the assessment period (2017-2023).
Increasing healthcare expenditure and government initiatives for R&D, are major tailwinds pushing the growth of the global impingement syndrome market.
High cost surgeries and lack of awareness about this disorder are major growth impeders for the global impingement syndrome market.
North America holds the largest share in the global impingement syndrome market, followed by Europe and the Asia Pacific, respectively.
ATOS Klinik Heidelberg GmbH & Co. KG (Germany), Johnson & Johnson Services, Inc. (US), DePuy Synthes (US), Stryker Corporation (US), Smith & Nephew (UK), Medtronic (Ireland), B. Braun Melsungen AG (Germany), Immediate Media Company Ltd. (US), and Abbott (US), are some of the top players operating in the global impingement syndrome market.
Table of Contents
1 Report Prologue
2 Introduction
2.1 Definition
2.2 Scope of Study:
2.3 Research Objective
2.4 Market Structure
3 Research Process
3.1 Primary Research
3.2 Secondary Research
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.3 Restraints
4.4 Opportunities
4.5 Macroeconomic Indicators
5. Market Factor Analysis
5.1 Porters five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain
5.3 Investment Feasibility Analysis
5.4 Price Factor Analysis
6 Global Impingement Syndrome Market, by Type
6.1 Introduction
6.2 Structural Impingement
6.3 Functional Impingement
7 Global Impingement Syndrome Market, By Diagnosis
7.1 Physical Examination
7.2 Imaging
7.2.1 Ultrasonography
7.2.2 Arthrography
7.2.3 MRI
8 Global Impingement Syndrome Market, By Treatment
8.1 Introduction
8.2 Drug Treatment
8.2.1 Corticosteroid
8.2.2 Local Anesthetic
8.2.3 NSAIDs
8.2.4 Other
8.3 Non-Pharmacological Treatment
8.3.1 Joint Mobilization
8.3.2 Interferential Therapy
8.3.3 Acupuncture
8.3.4 Soft Tissue Therapy
8.3.5 Therapeutic Taping
8.3.6 Rotator Cuff Strengthening
8.3.7 Other
8.4 Surgery
8.4.1 Arthroscopic Surgery
8.4.2 Open Surgery
8.4.3 Others
9 Global Impingement Syndrome Market, by End User
9.1 Introduction
9.2 Hospitals,
9.3 Physical Therapists
9.4 Others
10 Global Impingement syndrome Market by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 UK
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Republic Of Korea
10.4.5 Australia
10.4.6 Rest of Asia Pacific
10.5 Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of Middle East & Africa
11 Competitive Landscape
11.1 Introduction
11.2 Market share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
12 Company Profile
12.1 ATOS Klinik Heidelberg GmbH & Co. KG.
12.1.1Overview
12.1.2Product/Business Segment Overview
12.1.3Financial Overview
12.1.4Key Development
12.2 DePuy Synthes
12.2.1Overview
12.2.2Product/Business Segment Overview
12.2.3Financial Overview
12.2.4Key Developments
12.3 Johnson & Johnson Services, Inc.
12.3.1Overview
12.3.2Product/Business Segment Overview
12.3.3Financial Overview
12.3.4Key Developments
12.4 Stryker Corporation
12.4.1Overview
12.4.2Product/Business Segment Overview
12.4.3Financial Overview
12.4.4Key Developments
12.5 Medtronic
12.5.1Overview
12.5.2Product/Business Segment Overview
12.5.3Financials Updates
12.5.4Key Developments
12.6 Smith & Nephew
12.6.1Overview
12.6.2Product/Business Segment Overview
12.6.3Financial Updates
12.6.4Key Developments
12.7 B. Braun Melsungen AG
12.7.1Overview
12.7.2Product/Business Segment Overview
12.7.3Financial Updates
12.7.4Key Developments
12.8 Abbott
12.8.1Overview
12.8.2Product/Business Segment Overview
12.8.3Financial Updates
12.8.4Key Developments
12.9 Immediate Media Company Ltd.
12.9.1Overview
12.9.2Product/Business Segment Overview
12.9.3Financial Updates
12.9.4Key Developments
13 MRFR Conclusion
13.1 Key Findings
13.1.1From CEO’s View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Tissue Engineering Industries
14 Appendix
List of Tables
TABLE 1 GLOBAL IMPINGEMENT SYNDROME MARKET, BY TYPE, 2017-2023 (USD MILLION)
TABLE 2 STRUCTURAL IMPINGEMENT FOR IMPINGEMENT SYNDROME MARKET, BY REGION, 2017-2023 (USD MILLION)
TABLE 3 FUNCTIONAL IMPINGEMENT FOR IMPINGEMENT SYNDROME MARKET, BY REGION 2017-2023 (USD MILLION)
TABLE 4 GLOBAL IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2017-2023 (USD MILLION) TABLE
TABLE 5 GLOBAL IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2017-2023 (USD MILLION)
TABLE 6 GLOBAL IMPINGEMENT SYNDROME MARKET, BY END USER, 2017-2023 (USD MILLION)
TABLE 7 GLOBAL IMPINGEMENT SYNDROME MARKET, BY REGION 2017-2023 (USD MILLION)
TABLE 8 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY COUNTRY 2017-2023 (USD MILLION)
TABLE 9 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY TYPE 2017-2023 (USD MILLION)
TABLE 10 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2017-2023 (USD MILLION) TABLE
TABLE 11 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2017-2023 (USD MILLION)
TABLE 12 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY END USER, 2017-2023 (USD MILLION)
TABLE 13 NORTH AMERICA IMPINGEMENT SYNDROME MARKET BY REGION 2017-2023 (USD MILLION
TABLE 14 EUROPE IMPINGEMENT SYNDROME MARKET BY COUNTRY 2017-2023 (USD MILLION)
TABLE 15 EUROPE IMPINGEMENT SYNDROME MARKET, BY TYPE 2017-2023 (USD MILLION)
TABLE 16 EUROPE IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2017-2023 (USD MILLION) TABLE
TABLE 17 EUROPE IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2017-2023 (USD MILLION)
TABLE 18 EUROPE IMPINGEMENT SYNDROME MARKET, BY END USER, 2017-2023 (USD MILLION)
TABLE 19 EUROPE IMPINGEMENT SYNDROME MARKET, BY REGION 2017-2023 (USD MILLION)
TABLE 20 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY COUNTRY 2017-2023 (USD MILLION)
TABLE 21 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY TYPE 2017-2023 (USD MILLION)
TABLE 22 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2017-2023 (USD MILLION) TABLE
TABLE 23 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2017-2023 (USD MILLION)
TABLE 24 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY END USER, 2017-2023 (USD MILLION)
TABLE 25 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY REGION 2017-2023 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY REGION 2017-2023 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY TYPE 2017-2023 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2017-2023 (USD MILLION) TABLE
TABLE 29 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2017-2023 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY END USER, 2017-2023 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY REGION 2017-2023 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET DYNAMICS FOR GLOBAL IMPINGEMENT SYNDROME MARKET
FIGURE 3 ATTRITION RATE OF PHASE III CLINICAL TRIALS IN EUROPE, 2012
FIGURE 4 IMPINGEMENT SYNDROME SUCCESS RATES IN VARIOUS PHASES OF CLINICAL TRIALS
FIGURE 5 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY TYPE 2016
FIGURE 6 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY DAIGNOSIS, 2016
FIGURE 7 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY TREATMENT, 2016
FIGURE 8 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY END USER, 2016
FIGURE 9 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY REGION, 2016
FIGURE 10 NORTH AMERICA IMPINGEMENT SYNDROME MARKET SHARE, BY COUNTRY, 2016
FIGURE 11 EUROPE IMPINGEMENT SYNDROME MARKET SHARE, BY COUNTRY, 2016
FIGURE 12 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET SHARE, BY COUNTRY, 2016
FIGURE 13 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY REGION, 2016
FIGURE 14 GLOBAL IMPINGEMENT SYNDROME MARKET: COMPANY SHARE ANALYSIS, 2016 (%)
FIGURE 15 ATOS KLINIK HEIDELBERG GMBH & CO. KG.: KEY FINANCIALS
FIGURE 16 ATOS KLINIK HEIDELBERG GMBH & CO. KG.: SEGMENTAL REVENUE
FIGURE 17 ATOS KLINIK HEIDELBERG GMBH & CO. KG.: GEOGRAPHICAL REVENUE
FIGURE 18 DEPUY SYNTHES. KEY FINANCIALS
FIGURE 19 DEPUY SYNTHES. SEGMENTAL REVENUE
FIGURE 20 DEPUY SYNTHES: GEOGRAPHICAL REVENUE
FIGURE 21 JOHNSON & JOHNSON SERVICES, INC.: KEY FINANCIALS
FIGURE 22 JOHNSON & JOHNSON SERVICES, INC.: SEGMENTAL REVENUE
FIGURE 23 JOHNSON & JOHNSON SERVICES, INC.: GEOGRAPHICAL REVENUE
FIGURE 24 STRYKER CORPORATION. KEY FINANCIALS
FIGURE 25 STRYKER CORPORATION. SEGMENTAL REVENUE
FIGURE 26 STRYKER CORPORATION: GEOGRAPHICAL REVENUE
FIGURE 27 MEDTRONIC: FINANCIAL REVENUE
FIGURE 28 MEDTRONIC: SEGMENTAL REVENUE
FIGURE 29 MEDTRONIC: GEOGRPAHICAL REVENUE
FIGURE 30 SMITH & NEPHEW: FINANCIAL REVENUE
FIGURE 31 SMITH & NEPHEW: SEGMENTAL REVENUE
FIGURE 32 SMITH & NEPHEW: GEOGRPAHICAL REVENUE
FIGURE 33 B. BRAUN MELSUNGEN AG: FINANCIAL REVENUE
FIGURE 34 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE
FIGURE 35 B. BRAUN MELSUNGEN AG: GEOGRPAHICAL REVENUE
FIGURE 36 ABBOTT: FINANCIAL REVENUE
FIGURE 37 ABBOTT: SEGMENTAL REVENUE
FIGURE 38 ABBOTT: GEOGRPAHICAL REVENUE
